Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Receives $32.25 Consensus Target Price from Brokerages
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Free Report) has earned a consensus rating of “Buy” from the nine analysts that are currently covering the stock, MarketBeat Ratings reports. Eight research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year target […]
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Free Report) has earned a consensus rating of “Buy” from the nine analysts that are currently covering the stock, MarketBeat Ratings reports. Eight research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year target […]
